Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T08:25:01.839Z Has data issue: false hasContentIssue false
  • English
  • Français

The Possible Local Synthesis of Antibodies to Herpes Simplex Virus in Normal Cerebrospinal Fluid

Published online by Cambridge University Press:  18 September 2015

Anthony Science Russell
Anthony Science Russell*
Affiliation:
Rheumatic Disease Unit, University of Alberta, Edmonton, Alberta, Canada
*
Department of Medicine, 9-112 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, Canada T6G 2G3
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We have used the technique of antibody mediated cell dependent immune lysis to examine paired samples of serum and CSF for antibody to herpes simplex virus. The 40 patients studied had no inflammatory disease of the nervous system, yet 20 of the CSF specimens did have antiviral antibody. This is an extremely sensitive technique for the detection of at least one type of antiviral antibody and “in vitro” is a very effective way of killing virus infected cells. There is no correlation between the level of antiviral antibody in the CSF with the total protein content, but the high CSF: serum antibody ratio in some subjects who are particularly susceptible to recurrent herpes infection raises the possibility that local stimulation and production of this antibody may occur.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 3 , Issue 4 , November 1976 , pp. 219 - 221
Copyright
Copyright © Canadian Neurological Sciences Federation 1976

References

REFERENCES

Cappel, R., Thiry, L. and Clinet, G.(1975) . Viral antibodies in the CSF after acute CNS infection. Archives of Neurology, 32, 629–631.CrossRefGoogle Scholar
Lamoureux, F., Jollicoeur, R.. Giard, N., St-Hilaire, M. and Duplantis, F. (1975). Cerebrospinal fluid proteins in multiple sclerosis. Neurology. 25, 537–546.CrossRefGoogle ScholarPubMed
Lerner, A. M.. Lauter, C.B.. Nolan, D.C. and Shippey, M.J. (1972). Passive hemagglutinating antibodies in cerebrospinal fluids in herpes virus encephalitis. Proceedings of the Society for Experimental Biology and Medicine. 140, 1460–1466.CrossRefGoogle Scholar
Manconi, P.E, Zaccheo, D.. Bugiani, O., Sadda, M.F.. Grifoni, V. and Mantovani, G. (1976). T and B lymphocytes in normal cerebrospinal fluid. New England Journal of Medicine. 294, 49.Google Scholar
Rager-Zisman, B. and Allison, A.C. (1976) . Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-I) infection. Journal of Immunology, 116. 35–40.CrossRefGoogle Scholar
Russell, A.S.. Percy, J.S.. and Kovithavongs, T. (1975). Cell-mediated immunity to herpes simplex in humans: Lymphocyte cytotoxicity measured by 51Cr release from infected cells. Infection and Immunity. 11. 355–359.CrossRefGoogle ScholarPubMed
Russell, A.S. and Saetre, A (1976). Antibodies to herpes-simplex virus in “normal” cerebrospinal fluid. Lancet, 1, 64–65.CrossRefGoogle ScholarPubMed
Shore, S.L.. Black, C.M., Malewicz, M.F., Wood, A. and Nahmias, A.J. (1976). Antibody dependent cell mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. Journal of Immunology. 116. 194–201.CrossRefGoogle ScholarPubMed
Stevens, J.G. and Cook, M.L. (1974). Maintenance of latent herpetic infection: An apparent role for anti-viral IgG1. Journal of Immunology. 113. 1685–1693.CrossRefGoogle Scholar
Tourtelotte, W.W. (1972). Interaction of local central nervous system immunity and systemic immunity in the spread of multiple sclerosis demyelination. In: Wolgram, F. Ellison, G.W. Stevens, J.G. and Andrews, J.M. (Eds.). Multiple Sclerosis. Ch. 16, New York NY. Academic Press, pp. 285–332.Google Scholar
Yahr, M.D.. Goldensolm, S.S. and Kabot, E.A. (1954). Further studies on the gamma globulin content of cerebrospinal fluid in multiple sclerosis and other neurological diseases. Annals of the New York Academy of Sciences. 58, 613–627.CrossRefGoogle Scholar